Biospecifics Technologies (BSTC) Reports Q3 EPS of $0.39
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Net income (loss): 3.05M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income (loss): 3.05M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q3 EPS of $0.39, versus $0.20 reported last year. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $7.51 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
